BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9667571)

  • 1. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy.
    Boroojerdi B; Ferbert A; Schwarz M; Herath H; Noth J
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):111-4. PubMed ID: 9667571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
    McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of aberrant facial nerve regeneration with botulinum toxin A.
    Chua CN; Quhill F; Jones E; Voon LW; Ahad M; Rowson N
    Orbit; 2004 Dec; 23(4):213-8. PubMed ID: 15590522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland: a case report.
    Riemann R; Pfennigsdorf S; Riemann E; Naumann M
    Ophthalmology; 1999 Dec; 106(12):2322-4. PubMed ID: 10599665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin injection and tear production.
    Alsuhaibani AH; Eid SA
    Curr Opin Ophthalmol; 2018 Sep; 29(5):428-433. PubMed ID: 29994851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Involuntary lid closure caused by defective healing of facial paralysis and its treatment with botulinum toxin].
    Roggenkämper P; Laskawi R; Damenz W; Schröder M; Nüssgens Z
    Klin Monbl Augenheilkd; 1991 Apr; 198(4):268-70. PubMed ID: 1861404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin.
    Roggenkämper P; Laskawi R; Damenz W; Schröder M; Nüssgens Z
    Doc Ophthalmol; 1994; 86(4):395-402. PubMed ID: 7835177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation.
    Ito H; Ito H; Nakano S; Kusaka H
    Acta Neurol Scand; 2007 Apr; 115(4):271-4. PubMed ID: 17376126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation.
    Keegan DJ; Geerling G; Lee JP; Blake G; Collin JR; Plant GT
    Br J Ophthalmol; 2002 Jan; 86(1):43-6. PubMed ID: 11801502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
    Vargel I; Canter HI; Topaloglu H; Erk Y
    J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm.
    Lorenzano C; Bagnato S; Gilio F; Fabbrini G; Berardelli A
    Neurotox Res; 2006 Apr; 9(2-3):141-4. PubMed ID: 16785111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of blepharospasm and facial hemispasm with botulinum toxin. Apropos of 58 injections in 22 patients].
    Elbaz D
    Ann Otolaryngol Chir Cervicofac; 1994; 111(3):141-4. PubMed ID: 7840486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis.
    Lee JM; Choi KH; Lim BW; Kim MW; Kim J
    J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):71-8. PubMed ID: 25444667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
    Oliveira FC; Oliveira GC; Cariello AJ; Felberg S; Osaki MH
    Arq Bras Oftalmol; 2010; 73(5):405-8. PubMed ID: 21225122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
    Arat YO; Yen MT
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):22-4. PubMed ID: 17237684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local injection treatment with botulinum toxin A in blepharospasm, Meige syndrome and hemifacial spasm. Observations in 106 patients].
    Ceballos-Baumann AO; Gasser T; Dengler R; Oertel WH
    Nervenarzt; 1990 Oct; 61(10):604-10. PubMed ID: 2274092
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.
    Girard B; Piaton JM; Keller P; Nguyen TH
    J Fr Ophtalmol; 2018 Apr; 41(4):343-349. PubMed ID: 29681465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin treatment of synkinesia following facial paralysis].
    Roggenkämper P; Laskawi R; Damenz W; Schröder M; Nüssgens Z
    HNO; 1990 Aug; 38(8):295-7. PubMed ID: 2228744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland.
    Montoya FJ; Riddell CE; Caesar R; Hague S
    Eye (Lond); 2002 Nov; 16(6):705-9. PubMed ID: 12439663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.